Home » Key Scientific Articles Selection Criteria

Key Scientific Articles Selection Criteria

Global medical discovery series is the world’s leading source of medical research news and the authoritative source for scientific and medical discoveries and technologies that matter. We thrive to increase visibility of published research and provide access to global audience of researchers and experts.

Although many published papers in the literature might be of high quality and scientific merit but we very selective and only pick the highest in research excellence, creativity and novelty. Many factors are taken into account when evaluating papers for coverage in Global Medical Discovery news. Impact factor of the journal or location of researchers’ laboratory are not considered in the selection criteria for any category covered by Global Medical Discovery.

Key Scientific Articles

Key scientific article Global Medical Discovery selection criteria

Global Medical Discovery interested in covering the news of published papers that have  findings of exceptional significance in cell and molecular biology, structural biology, neuroscience, immunology, aging, virology and microbiology, cancer, human genetics, systems biology, cell signaling, and disease mechanisms and therapeutics. Only published papers with the highest quality research are chosen without regard for the impact factor of the published journal or the place of publication.

Key Stem cell research

Key Stem Cell Research Global Medical Discovery selection criteriaOur main objective in reporting the medical research news in stem cells is to increase the knowledge and awareness of stem cells with the ultimate aim of facilitating and advancing the cure of human diseases with such modern technologies.

Published papers that discuss timely novel discoveries and technical development of stem cell research including embryonic stem cells; induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: stem cell epigenetics, stem cell genomics and proteomics; cancer stem cells; translational and clinical stem cell research; and regenerative medicine.

We avoid papers that present just observational or too preliminary data with only incremental increase in our understanding in stem cells research. We prefer papers that expected to have broad readership and interest.

Key Nanotechnology Research articles

Key nanotechnology article Global Medical Discovery selection criteriaOur target selection team pick the highest quality and most significant in nanoscience and nanotechnology published papers related to biomedical sciences. We cover exciting papers dealing with nanobiotechnology, nanomedicine, carbon nanotubes, fullerenes, nanofluidics, and many kind of nanoparticles such as quantum dots, iron oxide , silver and gold nanoparticles either for improved medical diagnostic or drug delivery applications.

Key Medical Diagnostics Articles

Key Medical Diagnostic article Global Medical Discovery selection criteriaSelected published papers that report significant achievements in pathologic correlations in various diseases and improvements in molecular methods for diagnosis and monitoring of disease that is of interest to wide audience.  Priority will be given to innovative new technologies that could change medical practice. Published papers that demonstrate advancement in imaging technologies (X-ray radiography, magnetic resonance imaging, ultrasound, endoscopy,  thermography, and nuclear medicine (positron emission tomography). Measurements technologies covering novel applications of electroencephalography (EEG), magnetoencephalography (MEG), electrocardiography (ECG) are also considered.

Key Clinical Research Articles

Key Clinical Research article Global Medical Discovery selection criteriaWe select promising and innovative published papers that bridges between basic biomedical science and clinical medicine. Examples are papers that we believe will advance our understanding of the mechanisms of human disease such as those dealing with diagnostic, prognostic, and biomarker studies with clear clinical relevance. Published papers thought to cover clinical and translational research excellence in targeted therapies, personalized medicine as well as promising clinical trials are highly considered.